PATENT CLAIM ANALYSIS

Application Number: 15868301
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "296000"]

Abstract:
The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.

Claim (Index 42):
The method of  claim 40 , wherein the compound of Formula I-I or Formula I is administered in combination with one or more additional pharmaceutical agents.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.51351
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15041375', '14267011', '14772735', '14772726', '13899469']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8350616033241772
- 35 USC 102 Novelty (BERT): 0.5674167149039947
- Combined Prediction Score: 0.8082971144821589
- Mean Citation Score: 462.6317
- Max Citation Score: 543.9999
- Similarity Product: 343.6622674542189

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test